F0000007YS Comparative Analysis Breakdown

F0000007YS -- Ireland Fund  

GBp 1,324  6.00  0.45%

You can use this module to analyze advantages of F0000007YS technical and fundamental indicators over its peers. Please use the box above to enter up to 4 concurrent symbols you would like to analyze. Use comma (,) to separate each symbol. With this comparative module your can estimate the relative strength of F0000007YS against its competitors. Additionally see Investing Opportunities.

    
 Better Than Average     
    
 Worse Than Peers or Benchmark    View Performance Chart
F0000007YSBlackRock FIDFSPDR BarclaysPrusik AsiaJanus Global
6.00 / 0.45%

 1,324 

 F0000007YS
0.002 / 0.0141%

 14.14 

 BlackRock FIDF
30.19 / 9,223,372,036,855%

 30.19 

 SPDR Barclays
0.00 / 0.00%

 271.17 

 Prusik Asia
0.01 / 0.11%

 8.96 

 Janus Global
Market Performance
(Over the last 30 days)
 0 of 100 0 of 100 0 of 100 0 of 100 0 of 100
Probability Of Bankruptcy
(Chance of Financial Distress)
1 %1 %50 %1 %1 %
Net Asset
Minimum Initial Investment
Five Year Return
One Year Return
Price to Sales
Price to Book
Cash Position Weight
Equity Positions Weight
Year to Date Return
Three Year Return
Bond Positions Weight
Ten Year Return
Price to Earning
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Did You Try This Idea?

Run Obamacare Repeal Thematic Idea Now
Obamacare Repeal
Obamacare Repeal Idea
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Obamacare Repeal theme has 56 constituents.
View All  Next Launch Obamacare Repeal
Additionally see Investing Opportunities. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.